Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad s Q3 Sales Increase 9.4 Percent as R&D Spending, Profits Climb

NEW YORK, Nov. 4 (GenomeWeb News) - Bio-Rad Laboratories yesterday reported a 9.4-percent increase in net sales for the third quarter, which it attributed to strong sales in protein-expression analysis, process chromatography, diabetes monitoring, blood virus screening, and quality control products.

 

Net sales for the quarter ended Sept. 30 increased to $283.2 million from $258.8 million for the third quarter last year.

 

R&D spending in the quarter increased 8 percent to $28.7 million from $26.6 million during the same period last year.

 

Third quarter income from continuing operations was up 158 percent to $16.2 million, or $.62 cents per share, from $6.2 million, or $.24 per share, during the same period last year.

 

As of Sept. 30, BioRad had $244 million in cash and cash equivalents.

 

BioRad said that sales in its life science business could be hurt by a lawsuit against Applera and Roche that prevents the company from selling its MJ Research line of thermal cycling products acquired in August 2004.

 

Sales in life sciences could be reduced by as much as $10 million to $15 million during the fourth quarter due to a lawsuit, and pre-tax operating profit could be reduced by $8 million to $10 million compared to prior expectations, the company said.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.